These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20082655)

  • 1. β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure.
    Machackova J; Sanganalmath SK; Elimban V; Dhalla NS
    J Cell Mol Med; 2011 Mar; 15(3):545-54. PubMed ID: 20082655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of cardiac remodeling in congestive heart failure by beta-adrenoceptor blockade is associated with depression in sympathetic activity.
    Machackova J; Sanganalmath SK; Barta J; Dhalla KS; Dhalla NS
    Cardiovasc Toxicol; 2010 Mar; 10(1):9-16. PubMed ID: 19949891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure.
    Sanganalmath SK; Babick AP; Barta J; Kumamoto H; Takeda N; Dhalla NS
    J Cell Mol Med; 2008; 12(5A):1728-38. PubMed ID: 18088389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure.
    Litwin SE; Katz SE; Morgan JP; Douglas PS
    Br J Pharmacol; 1999 Aug; 127(7):1671-9. PubMed ID: 10455325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of cardiac dysfunction and subcellular alterations by metoprolol in heart failure due to myocardial infarction.
    Babick A; Elimban V; Zieroth S; Dhalla NS
    J Cell Physiol; 2013 Oct; 228(10):2063-70. PubMed ID: 23553674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
    Yaoita H; Sakabe A; Maehara K; Maruyama Y
    Circulation; 2002 Feb; 105(8):975-80. PubMed ID: 11864928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan.
    Wang J; Guo X; Dhalla NS
    Biochim Biophys Acta; 2004 Oct; 1690(2):177-84. PubMed ID: 15469907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil.
    Takeo S; Elmoselhi AB; Goel R; Sentex E; Wang J; Dhalla NS
    Mol Cell Biochem; 2000 Oct; 213(1-2):111-8. PubMed ID: 11129949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction.
    Babick A; Chapman D; Zieroth S; Elimban V; Dhalla NS
    J Cell Mol Med; 2012 Dec; 16(12):2958-67. PubMed ID: 22947202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
    Guo X; Wang J; Elimban V; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of low and high doses of carvedilol on restoration of cardiac function and calcium-handling proteins in rat failing heart.
    Sun YL; Hu SJ; Wang LH; Hu Y; Zhou JY
    Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):553-60. PubMed ID: 16026515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent β-adrenergic blockade downregulates the gene expression of β-myosin heavy chain in the mouse heart.
    Maccari S; Pace V; Barbagallo F; Stati T; Ambrosio C; Grò MC; Molinari P; Vezzi V; Catalano L; Matarrese P; Patrizio M; Rizzi R; Marano G
    Eur J Pharmacol; 2020 Sep; 882():173287. PubMed ID: 32585157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
    Sanganalmath SK; Barta J; Takeda N; Kumamoto H; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):180-9. PubMed ID: 18418427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.
    Omerovic E; Bollano E; Soussi B; Waagstein F
    Eur J Heart Fail; 2003 Dec; 5(6):725-32. PubMed ID: 14675850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in rats.
    Shimada T; Yoshiyama M; Takeuchi K; Omura T; Takemoto Y; Kim S; Iwao H; Yoshikawa J
    Cardiovasc Res; 1998 Mar; 37(3):618-26. PubMed ID: 9659445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why do patients with congestive heart failure tolerate the initiation of beta-blocker therapy?
    Haber HL; Simek CL; Gimple LW; Bergin JD; Subbiah K; Jayaweera AR; Powers ER; Feldman MD
    Circulation; 1993 Oct; 88(4 Pt 1):1610-9. PubMed ID: 8104738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion.
    Latini R; Masson S; Jeremic G; Luvarà G; Fiordaliso F; Calvillo L; Bernasconi R; Torri M; Rondelli I; Razzetti R; Bongrani S
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):601-8. PubMed ID: 9554811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
    Mulder P; Richard V; Bouchart F; Derumeaux G; Münter K; Thuillez C
    Cardiovasc Res; 1998 Sep; 39(3):600-8. PubMed ID: 9861302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of long-term beta-blockade in experimental chronic aortic regurgitation.
    Plante E; Lachance D; Champetier S; Drolet MC; Roussel E; Arsenault M; Couet J
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1888-95. PubMed ID: 18296565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.